Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III)

Thomas Reiberger; Andreas Püspök; Maria Schoder; Franziska Baumann-Durchschein; Theresa Bucsics; Christian Datz; Werner Dolak; Arnulf Ferlitsch; Armin Finkenstedt; Ivo Graziadei; Stephanie Hametner; Franz Karnel; Elisabeth Krones; Andreas Maieron; Mattias Mandorfer; Markus Peck-Radosavljevic; Florian Rainer; Philipp Schwabl; Vanessa Stadlbauer; Rudolf Stauber; Herbert Tilg; Michael Trauner; Heinz Zoller; Rainer Schöfl; Peter Fickert

doi:10.1007/s00508-017-1262-3

Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III)

Thomas Reiberger
, Andreas Püspök
, Maria Schoder
, Franziska Baumann-Durchschein
, Theresa Bucsics
, Christian Datz
, Werner Dolak
, Arnulf Ferlitsch
, Armin Finkenstedt
, Ivo Graziadei
, Stephanie Hametner
, Franz Karnel
, Elisabeth Krones
, Andreas Maieron
, Mattias Mandorfer
, Markus Peck-Radosavljevic
, Florian Rainer
, Philipp Schwabl
, Vanessa Stadlbauer
, Rudolf Stauber

Herbert Tilg, Michael Trauner, Heinz Zoller, Rainer Schöfl, Peter Fickert

Research output: Journal article (peer-reviewed) › Journal article

132 Citations (Scopus)

Abstract

The Billroth III guidelines were developed during a consensus meeting of the Austrian Society of Gastroenterology and Hepatology (ÖGGH) and the Austrian Society of Interventional Radiology (ÖGIR) held on 18 February 2017 in Vienna. Based on international guidelines and considering recent landmark studies, the Billroth III recommendations aim to help physicians in guiding diagnostic and therapeutic strategies in patients with portal hypertension.

Original language	English
Pages (from-to)	135-158
Number of pages	24
Journal	Wiener Klinische Wochenschrift
Volume	129
Issue number	Suppl 3
DOIs	https://doi.org/10.1007/s00508-017-1262-3
Publication status	Published - 01 Nov 2017
Externally published	Yes

Keywords

Austria
Carbazoles/therapeutic use
Carvedilol
Comorbidity
Early Medical Intervention
Esophageal and Gastric Varices/prevention & control
Gastrointestinal Hemorrhage/prevention & control
Humans
Hypertension, Portal/diagnosis
Liver Cirrhosis/diagnosis
Mass Screening
Propanolamines/therapeutic use
Propranolol/therapeutic use
Randomized Controlled Trials as Topic
Timolol/therapeutic use

Access to Document

10.1007/s00508-017-1262-3

Cite this

Reiberger, T., Püspök, A., Schoder, M., Baumann-Durchschein, F., Bucsics, T., Datz, C., Dolak, W., Ferlitsch, A., Finkenstedt, A., Graziadei, I., Hametner, S., Karnel, F., Krones, E., Maieron, A., Mandorfer, M., Peck-Radosavljevic, M., Rainer, F., Schwabl, P., Stadlbauer, V., ... Fickert, P. (2017). Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III). Wiener Klinische Wochenschrift, 129(Suppl 3), 135-158. https://doi.org/10.1007/s00508-017-1262-3

@article{76865620bbb943aab49d57b017c0cddd,

title = "Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III)",

abstract = "The Billroth III guidelines were developed during a consensus meeting of the Austrian Society of Gastroenterology and Hepatology ({\"O}GGH) and the Austrian Society of Interventional Radiology ({\"O}GIR) held on 18 February 2017 in Vienna. Based on international guidelines and considering recent landmark studies, the Billroth III recommendations aim to help physicians in guiding diagnostic and therapeutic strategies in patients with portal hypertension.",

keywords = "Austria, Carbazoles/therapeutic use, Carvedilol, Comorbidity, Early Medical Intervention, Esophageal and Gastric Varices/prevention \& control, Gastrointestinal Hemorrhage/prevention \& control, Humans, Hypertension, Portal/diagnosis, Liver Cirrhosis/diagnosis, Mass Screening, Propanolamines/therapeutic use, Propranolol/therapeutic use, Randomized Controlled Trials as Topic, Timolol/therapeutic use",

author = "Thomas Reiberger and Andreas P{\"u}sp{\"o}k and Maria Schoder and Franziska Baumann-Durchschein and Theresa Bucsics and Christian Datz and Werner Dolak and Arnulf Ferlitsch and Armin Finkenstedt and Ivo Graziadei and Stephanie Hametner and Franz Karnel and Elisabeth Krones and Andreas Maieron and Mattias Mandorfer and Markus Peck-Radosavljevic and Florian Rainer and Philipp Schwabl and Vanessa Stadlbauer and Rudolf Stauber and Herbert Tilg and Michael Trauner and Heinz Zoller and Rainer Sch{\"o}fl and Peter Fickert",

note = "Publisher Copyright: {\textcopyright} 2017, The Author(s).",

year = "2017",

month = nov,

day = "1",

doi = "10.1007/s00508-017-1262-3",

language = "English",

volume = "129",

pages = "135--158",

journal = "Wiener Klinische Wochenschrift",

issn = "0043-5325",

publisher = "Springer",

number = "Suppl 3",

}

Reiberger, T, Püspök, A, Schoder, M, Baumann-Durchschein, F, Bucsics, T, Datz, C, Dolak, W, Ferlitsch, A, Finkenstedt, A, Graziadei, I, Hametner, S, Karnel, F, Krones, E, Maieron, A, Mandorfer, M, Peck-Radosavljevic, M, Rainer, F, Schwabl, P, Stadlbauer, V, Stauber, R, Tilg, H, Trauner, M, Zoller, H, Schöfl, R & Fickert, P 2017, 'Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III)', Wiener Klinische Wochenschrift, vol. 129, no. Suppl 3, pp. 135-158. https://doi.org/10.1007/s00508-017-1262-3

TY - JOUR

T1 - Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III)

AU - Reiberger, Thomas

AU - Püspök, Andreas

AU - Schoder, Maria

AU - Baumann-Durchschein, Franziska

AU - Bucsics, Theresa

AU - Datz, Christian

AU - Dolak, Werner

AU - Ferlitsch, Arnulf

AU - Finkenstedt, Armin

AU - Graziadei, Ivo

AU - Hametner, Stephanie

AU - Karnel, Franz

AU - Krones, Elisabeth

AU - Maieron, Andreas

AU - Mandorfer, Mattias

AU - Peck-Radosavljevic, Markus

AU - Rainer, Florian

AU - Schwabl, Philipp

AU - Stadlbauer, Vanessa

AU - Stauber, Rudolf

AU - Tilg, Herbert

AU - Trauner, Michael

AU - Zoller, Heinz

AU - Schöfl, Rainer

AU - Fickert, Peter

PY - 2017/11/1

Y1 - 2017/11/1

N2 - The Billroth III guidelines were developed during a consensus meeting of the Austrian Society of Gastroenterology and Hepatology (ÖGGH) and the Austrian Society of Interventional Radiology (ÖGIR) held on 18 February 2017 in Vienna. Based on international guidelines and considering recent landmark studies, the Billroth III recommendations aim to help physicians in guiding diagnostic and therapeutic strategies in patients with portal hypertension.

AB - The Billroth III guidelines were developed during a consensus meeting of the Austrian Society of Gastroenterology and Hepatology (ÖGGH) and the Austrian Society of Interventional Radiology (ÖGIR) held on 18 February 2017 in Vienna. Based on international guidelines and considering recent landmark studies, the Billroth III recommendations aim to help physicians in guiding diagnostic and therapeutic strategies in patients with portal hypertension.

KW - Austria

KW - Carbazoles/therapeutic use

KW - Carvedilol

KW - Comorbidity

KW - Early Medical Intervention

KW - Esophageal and Gastric Varices/prevention & control

KW - Gastrointestinal Hemorrhage/prevention & control

KW - Humans

KW - Hypertension, Portal/diagnosis

KW - Liver Cirrhosis/diagnosis

KW - Mass Screening

KW - Propanolamines/therapeutic use

KW - Propranolol/therapeutic use

KW - Randomized Controlled Trials as Topic

KW - Timolol/therapeutic use

UR - https://www.scopus.com/pages/publications/85031917456

U2 - 10.1007/s00508-017-1262-3

DO - 10.1007/s00508-017-1262-3

M3 - Journal article

C2 - 29063233

SN - 0043-5325

VL - 129

SP - 135

EP - 158

JO - Wiener Klinische Wochenschrift

JF - Wiener Klinische Wochenschrift

IS - Suppl 3

ER -

Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III)

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this